Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists — Takahiro Yamazaki (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Shared by
Guido Guido Kroemer
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
Article
2013
en
Authors
+11 more
TY
Takahiro Yamazaki
DH
Dalil Hannani
VP
Vichnou Poirier-Colame
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2019
Methods for measuring HMGB1 release during immunogenic cell death
Liwei Zhao
,
Peng Liu
,
Oliver Kepp
,
Guido Guido Kroemer
Article
2013
Immunogenic cell death in radiation therapy
Lorenzo Galluzzi
,
Oliver Kepp
,
Guido Guido Kroemer
Article
2012
Immunogenic Cell Death in Cancer Therapy
Guido Guido Kroemer
,
Lorenzo Galluzzi
,
Oliver Kepp
,
Laurence Zitvogel
Editorial Material
2023
Immunogenic Cell Stress and Death Sensitize Tumors to Immunotherapy
Oliver Kepp
,
Guido Guido Kroemer
Article
2017
Photodynamic therapy with redaporfin induces ER stress and immunogenic cell death
Lígia C. Gomes‐da‐Silva
,
Lucillia Bezu
,
Allan Sauvat
,
Heng Zhou
,
Sylvère Durand
,
Gérard Pierron
,
Oliver Kepp
,
Luı́s G. Arnaut
,
Guido Guido Kroemer
Discussion(0)
No comments yet. Be the first to comment.